Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8804 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8764 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8626 |
High Similarity |
NPD8312 |
Approved |
0.8626 |
High Similarity |
NPD8313 |
Approved |
0.8571 |
High Similarity |
NPD7808 |
Phase 3 |
0.8516 |
High Similarity |
NPD7251 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8407 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8325 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8324 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8306 |
Intermediate Similarity |
NPD7472 |
Approved |
0.827 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8256 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8251 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8216 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.8214 |
Intermediate Similarity |
NPD8319 |
Approved |
0.8156 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8142 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.81 |
Intermediate Similarity |
NPD7874 |
Approved |
0.81 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.809 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.809 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8087 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8087 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8087 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8071 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8071 |
Intermediate Similarity |
NPD7697 |
Approved |
0.8065 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.801 |
Intermediate Similarity |
NPD6779 |
Approved |
0.801 |
Intermediate Similarity |
NPD6780 |
Approved |
0.801 |
Intermediate Similarity |
NPD6778 |
Approved |
0.801 |
Intermediate Similarity |
NPD6776 |
Approved |
0.801 |
Intermediate Similarity |
NPD6782 |
Approved |
0.801 |
Intermediate Similarity |
NPD6781 |
Approved |
0.801 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7989 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7957 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.794 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.794 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7908 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7906 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7903 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7903 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7889 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD7801 |
Approved |
0.788 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7821 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7802 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7755 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7747 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7747 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7722 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7662 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD2533 |
Approved |
0.764 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD2532 |
Approved |
0.764 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7637 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7637 |
Intermediate Similarity |
NPD37 |
Approved |
0.7629 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7609 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7596 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7581 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7568 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7556 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7553 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7473 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7413 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7401 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7345 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7264 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7264 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7264 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7264 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7263 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7253 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7225 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7212 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7173 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD919 |
Approved |
0.7136 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD8067 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7064 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7053 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7014 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD6190 |
Approved |
0.6989 |
Remote Similarity |
NPD920 |
Approved |
0.6982 |
Remote Similarity |
NPD8469 |
Approved |
0.6979 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD2800 |
Approved |
0.6973 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6967 |
Remote Similarity |
NPD7999 |
Approved |
0.6954 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6952 |
Remote Similarity |
NPD1653 |
Approved |
0.6944 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6944 |
Remote Similarity |
NPD3748 |
Approved |
0.694 |
Remote Similarity |
NPD7003 |
Approved |
0.6937 |
Remote Similarity |
NPD8491 |
Approved |
0.6923 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.691 |
Remote Similarity |
NPD1240 |
Approved |
0.6906 |
Remote Similarity |
NPD5404 |
Approved |
0.6906 |
Remote Similarity |
NPD5405 |
Approved |
0.6906 |
Remote Similarity |
NPD5406 |
Approved |
0.6906 |
Remote Similarity |
NPD5408 |
Approved |
0.6904 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6885 |
Remote Similarity |
NPD1243 |
Approved |
0.6882 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6868 |
Remote Similarity |
NPD7266 |
Discontinued |
0.685 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6845 |
Remote Similarity |
NPD6273 |
Approved |
0.6842 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD6651 |
Approved |
0.6832 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6818 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6816 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6812 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6804 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6802 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD2403 |
Approved |
0.6798 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD6798 |
Discontinued |
0.678 |
Remote Similarity |
NPD4287 |
Approved |
0.6778 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6778 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD5763 |
Approved |
0.6776 |
Remote Similarity |
NPD5762 |
Approved |
0.6774 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6749 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6721 |
Remote Similarity |
NPD2438 |
Suspended |
0.6704
|
Remote Similarity |
NPD3268 |
Approved |